Drug Trial News

RSS

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Ferring Pharmaceuticals announced today a new analysis of data from the Phase 3 ESTHER-1 trial showing that natural variations in anti-Müllerian hormone levels during and between a woman's menstrual cycle have no clinically relevant impact on ovarian response when using AMH to dose Rekovelle for ovarian stimulation.

2 Jul 2018

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.

30 Jun 2018

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator on the first trial and as local PI on three other trials.

30 Jun 2018

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

29 Jun 2018

Children's Colorado participates in cystic fibrosis triple combination therapy trials

Children's Hospital Colorado has announced that its Mike McMorris Cystic Fibrosis Research and Care Center, one of the largest cystic fibrosis clinical care centers in the U.S., is participating in one of two Phase Three clinical trials related to the development of a possible breakthrough therapy for people with CF.

29 Jun 2018

Worldwide study to examine new treatments for IgA nephropathy

A patient from Birmingham is the first person to be recruited into a new worldwide study to test new treatments for a potentially life-threatening kidney condition called IgA nephropathy.

28 Jun 2018

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen, which is commonly expressed on prostate cancer cells.

22 Jun 2018

New study is testing safety and efficacy of glycoside in breaking up kidney stones

For anyone who has suffered from kidney stones, the painful condition is not easily treatable, and patients are typically prescribed strong pain medication and fluids to alleviate symptoms.

20 Jun 2018

New guidance on selection and evaluation of wearable devices for use in regulatory clinical trials

Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new guidance regarding the selection and evaluation of wearable devices for use in regulatory trials and to support labeling claims.

19 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

New clinical trial finds no evidence to support use of tamsulosin for kidney stones

The latest research into finding medications to aid the passage of ureteral or kidney stones has shown that tamsulosin is not effective for patients across the board.

18 Jun 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Drug Trial News

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Children's Colorado participates in cystic fibrosis triple combination therapy trials

Worldwide study to examine new treatments for IgA nephropathy

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

New study is testing safety and efficacy of glycoside in breaking up kidney stones

New guidance on selection and evaluation of wearable devices for use in regulatory clinical trials

Clinical trial targets metastatic colorectal cancer with new combination therapy

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

New clinical trial finds no evidence to support use of tamsulosin for kidney stones

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

NIAID launches clinical trial of investigational RSV vaccine

Topical gel may lower breast cancer risk in women with dense breast tissue

New clinical trial of MS drug will be first to recognize needs of wheelchair users

Metric-based virtual reality simulation improves training for physicians in mechanical thrombectomy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News